STAT+: Pharmalittle: New York officials press pharmacy chains over abortion pill; Sanders pushes bill for $20 insulin cap

Roche’s failed Alzheimer’s studies lend weight to an emerging idea about potential treatments. […]

A small but growing community of CEOs and scientists are trying to recast the story of longevity so it’s digestible to the drug-making mainstream: less cover of Time magazine, more… […]

Ginkgo, a company that said its engineered cells could help make almost anything, is trying to drum up business. […]